XML 62 R51.htm IDEA: XBRL DOCUMENT v3.24.3
REVENUE, CREDIT CONCENTRATIONS AND GEOGRAPHIC INFORMATION - Narrative (Details)
$ in Thousands
9 Months Ended 12 Months Ended
Sep. 30, 2024
USD ($)
segment
Dec. 31, 2023
USD ($)
Concentration Risk And Geographic Information [Line Items]    
Number of operating business segment | segment 1  
Accounts receivable, net $ 777,547 $ 633,704 [1]
Sanofi    
Concentration Risk And Geographic Information [Line Items]    
Accounts receivable, net $ 94,200 $ 63,400
Credit Concentration Risk | Accounts Receivable | Customer One    
Concentration Risk And Geographic Information [Line Items]    
Concentration risk, percentage 18.00% 15.00%
Credit Concentration Risk | Accounts Receivable | Customer Two    
Concentration Risk And Geographic Information [Line Items]    
Concentration risk, percentage   12.00%
[1]
(1)December 31, 2023 balances were derived from the audited Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, filed with the SEC on February 26, 2024.